Psilocybin
Treatment‑Resistant Depression
PreclinicalActive
Key Facts
About Shields Pharma
A private biotech developing cGMP‑grade psychedelic medicines and contract analytical services for mental health and addiction.
View full company profileAbout EYWA
Sustainable, clinical‑grade psychedelics for next‑generation mental health therapies.
View full company profileTherapeutic Areas
Other Treatment‑Resistant Depression Drugs
| Drug | Company | Phase |
|---|---|---|
| ALA-3000 | Alar Pharmaceuticals | Phase 1 |